HEALTH● LOWAug 12 · Aug 12, 2026, 11:58 PM
Seastar medical targets NEUTRALIZE-AKI enrollment completion around year-end or Q1 2027 as QUELIMMUNE adoption reaches 20 hospitals
Seeking Alpha Tech
Seastar Medical aims to complete enrollment for its NEUTRALIZE-AKI study around year-end or Q1 2027, while its QUELIMMUNE product has been adopted by 20 hospitals.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoCan’t ask mosquitoes not to bite: Bengal Minister’s remark sparks criticismThe HinduHEALTH2h agoSuspected opioid overdose deaths rise as police issue new alert for Canberra | The Canberra Timescanberratimes.com.au · AustraliaHEALTH2h agoFrance: pumpkin seeds recalled after more than 80 salmonella casesEuroNews [en]HEALTH3h agoMaharashtra Bill does not regulate private hospital treatment rates, says health right groupThe Hindu